Cargando…

Mirror-Image Lesions in Sequential Relapses of AQP4-Positive Neuromyelitis Optica Spectrum Disorder

A 25 year-old Nigerian woman with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) presented with a 6 week history of nausea, vomiting, and refractory hiccups; as well as progressive lower extremity sensory loss, weakness, saddle anesthesia, and urinary incontinence. She...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muir, Ryan T., Bharatha, Aditya, Rotstein, Dalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235314/ https://www.ncbi.nlm.nih.gov/pubmed/32477258 http://dx.doi.org/10.3389/fneur.2020.00414

Ejemplares similares

Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer—A case series
por: Duan, Yinghui, et al.
Publicado: (2022)

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
por: Clarke, Laura, et al.
Publicado: (2021)

Pregnancy and Neuromyelitis Optica Spectrum Disorder – Reciprocal Effects and Practical Recommendations: A Systematic Review
por: D'Souza, Rohan, et al.
Publicado: (2020)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report
por: Chatterton, Sophie, et al.
Publicado: (2022)

Editorial: Advances in neuromyelitis optica spectrum disorders
por: Cai, Yu, et al.
Publicado: (2022)

Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
por: Boldrini, Vinícius Oliveira, et al.
Publicado: (2023)

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
por: Singh, Pratap, et al.
Publicado: (2021)

Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder
por: Thöne, Jan, et al.
Publicado: (2018)

Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody
por: Wang, Liang, et al.
Publicado: (2022)

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
por: Palace, Jacqueline, et al.
Publicado: (2019)

Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Cortical Thinning and Ventricle Enlargement in Neuromyelitis Optica Spectrum Disorders
por: Tian, De-Cai, et al.
Publicado: (2020)

Serum Homocysteine Level Is a Predictor of Relapse and Prognosis in Patients With First-Attack Neuromyelitis Optica Spectrum Disorders
por: Zhang, Jinwei, et al.
Publicado: (2021)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome
por: Ji, Qiling, et al.
Publicado: (2022)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

Serum antinuclear antibodies associate with worse prognosis in AQP4‐positive neuromyelitis optica spectrum disorder
por: Fan, Rong, et al.
Publicado: (2020)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
por: Berthele, Achim, et al.
Publicado: (2023)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2020)

Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Arslan, Burak, et al.
Publicado: (2021)

Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder
por: Rao, Jie, et al.
Publicado: (2022)

Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders
por: Motamedi, Seyedamirhosein, et al.
Publicado: (2020)

White Matter Network Disruption and Cognitive Dysfunction in Neuromyelitis Optica Spectrum Disorder
por: Cho, Eun Bin, et al.
Publicado: (2018)

Neuromyelitis Optica Spectrum Disorder: A Rare Case of Isolated Brainstem Syndrome
por: Bui, Mai-Lynn, et al.
Publicado: (2019)

Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
por: Kong, Lingyao, et al.
Publicado: (2022)

Understanding the employment impact of neuromyelitis optica spectrum disorder in the USA: Mixed methods
por: Mateen, Farrah J., et al.
Publicado: (2023)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang, Ting-Ting, et al.
Publicado: (2016)

Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population
por: Mao, Zhifeng, et al.
Publicado: (2015)

The Spectrum of Clinical Presentation of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Young Patients of Our Community
por: Sherani, Hikmatullah K, et al.
Publicado: (2021)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features
por: Oertel, Frederike Cosima, et al.
Publicado: (2019)

The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk
por: Yin, Hexiang, et al.
Publicado: (2021)

Superficial Macula Capillary Complexity Changes Are Associated With Disability in Neuromyelitis Optica Spectrum Disorders
por: Wei, Ruili, et al.
Publicado: (2021)

An Experimental Model of Neuromyelitis Optica Spectrum Disorder–Optic Neuritis: Insights Into Disease Mechanisms
por: Soerensen, Sofie Forsberg, et al.
Publicado: (2021)

Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kleerekooper, Iris, et al.
Publicado: (2020)

Neuromyelitis Optica Spectrum Disorder: A Rare Case of Transverse Myelitis and Autonomic Dysfunction
por: Bugshan, Turki F, et al.
Publicado: (2023)

Analysis of Predictive Risk Factors in Aquaporin-4-IgG Positive Highly Active Neuromyelitis Optica Spectrum Disorders
por: Li, Yanfei, et al.
Publicado: (2021)

Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder
por: Li, Zhichao, et al.
Publicado: (2023)

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course
por: Solomon, Jacqueline M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nmt5o4koan7p4es3u81rg8rmhd